HSCS Stock Alert: HeartSciences Receives Israeli Patent for AI Heart-Disease Detector


  • HeartSciences (HSCS) stock is moving after getting a new patent in Israel.
  • This covers the company’s ECG devices.
  • HeartSciences is seeking to integrate artificial intelligence (AI) into its devices.
hands holding a red heart shape against blue background symbolizing health HSCS Stock.

Source: shutterstock.com/Anastasia Zagoruyko

HeartSciences (NASDAQ:HSCS) stock is on the move Monday as investors react to a new patent granted by the Israel Patent Office.

This patent covers the use of artificial intelligence (AI) alongside the company’s ECG devices. The company believes it can make ECG a more useful device for screening heart problems with the help of AI.

HeartSciences notes that this new patent further protects the company’s IP, or intellectual property. The company already has nine patents in the U.S. and 31 in international markets. It’s also awaiting approval for eight patents filed in the U.S. and other areas.

Andrew Simpson, CEO of HeartSciences, said the following about the news:

“Artificial intelligence is transforming what’s possible, and at HeartSciences we are at the leading edge of changing what’s possible with an ECG by applying AI to make it a far more valuable screening tool for heart disease detection to save lives.”

How HSCS Stock Is Reacting

With today’s patent news comes heavy trading of HSCS stock. As of this writing, more than 3 million shares have changed hands. That’s already above the company’s daily average trading volume of about 2.5 million shares.

HSCS stock is down 17.7% as of Monday morning following a rally in pre-market trading today.

Investors looking for all of the latest stock market news are in the right place!

InvestorPlace has all of the most recent stock news traders need to know about on Monday! Among that is what has shares of Dell Technologies (NYSE:DELL), Aerwins (NASDAQ:AWIN) and Alset (NASDAQ:AEI) stock on the move today. You can read up on all that news at the following links!

More Monday Stock Market News

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Article printed from InvestorPlace Media, https://investorplace.com/2023/02/hscs-stock-alert-heartsciences-receives-israeli-patent-for-ai-heart-disease-detector/.

©2024 InvestorPlace Media, LLC